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hyde dehydrogenase) reporting (via NADH production) on
the turnover of anallylic ethylcarbonate substrate in an upper
organic reaction layer. The first examples of asymmetric,
Ni(0)-mediated allylic amination reactions were uncovered
in the process.

METHOD FORMONITORING THE
STEREOSELECTIVITY AND RELATIVE
RATE OF ORGANIC CHEMICAL
REACTIONS

This application claims benefit to provisional application
60/681,157 filed May 16, 2005.
This invention was made with government Support under
CHE0317083 awarded by the National Science Foundation.
The government has certain rights in the invention.

BRIEF SUMMARY OF THE INVENTION

10

FIELD OF THE INVENTION

This invention relates to a method for the in situ monitoring
of stereoselectivities and relative rates of reaction.

15

BACKGROUND OF THE INVENTION

Combinatorial methods have made an important impact on
catalyst discovery in recent years. Notable examples include
the discovery of catalysts for asymmetric acylation and Stet
ter-type chemistry, Pd(0) and Cu(I)-mediated allylic alkyla
tions, Ag-based carbene insertion, FeCl-mediated epoxida
tion, and early transition metal-based additions to imines.
These Successes have spurred interest in catalyst Screening.
Thus, screens for active lead catalysts, based upon IR ther
mography fluorescence and dye formation/bleaching have
been reported. However, some methods for estimating rela
tive rates, for example, involve the alteration of the substrate
by the installation of a chromophore. In some cases, the
Substrate is so significantly altered, that a positive result in the
screen, does not translate into a positive result with the origi
nal, unperturbed Substrate.
Particularly valuable screens also provide information on
enantioselectivity. Such screening methods include chiral GC
and HPLC, CD and ORD and methods based upon installing
MS or fluorescence tags or condensations with indicators.
The most common methods for estimating enantioselec
tivity are time-consuming and serial in nature. They involve
chiral chromatography (usually HPLC or GC), and can be
automated by the use of auto-injectors, but have the disad
Vantages of (i) requiring reaction quenching and work-up and
of (ii) offering little possibility for parallel screening. Other
approaches to estimating enantiomeric excess require that the
product be derivatized, in a separate kinetic resolution step,
following work-up of the reaction.
A reported in sits screen that provides information on both
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relative rate and productee employs an isotopically chiral'C

NMR probe substrate. This allows obtaining information on
both relative rate and enantioselectivity of the catalyst being
screened, on the fly, without the need to draw aliquots. The
disadvantage of that method is that it requires the Stereose
lective synthesis of an expensive 13-C-enriched model sub
strate. Furthermore, this approach placed the isotopically
chiral, geminal dimethyl reporting group directly adjacent
to the carbonyl reaction center, thereby creating steric hin
drance. This limits the suitability of the model substrate to
mimic more common Substrates for carbonyl addition reac
tions that possess sterically less hindered carbonyl groups.
As described in U.S. Pat. No. 6,974,665, the entire disclo

sure of which is incorporated herein by reference, enzymes
can be used to assist organic chemists, using an approach
termed “in situ enzymatic screening (ISES). Enzymes are
used to monitor relative rates in real time for allylic substitu
tion catalysts run in parallel. ISES(InSitu Enzymatic Screen
ing) is run in a bilayer, in this case, with a lower, aqueous
enzymatic layer (containing ethanol dehydrogenase and alde

One embodiment of the present invention provides a
method for monitoring the stereoselectivity of at least one
organic chemical reaction and the relative rate of at least one
organic chemical reaction, wherein the reaction produces a
product that can exist as at least two stereoisomers, the pro
cess comprising:
providing a first reaction Zone containing (1) an organic
phase comprising the reaction mixture for producing the
product and (2) an aqueous phase adjacent to but Substantially
immiscible with the organic phase, the aqueous phase con
taining at least one first sensing agent that preferentially acts
ona first stereoisomer in the product to produce a monitorable
change, the product being diffusible into the aqueous layer
(2).
providing a second reaction Zone containing (A) an organic
phase also comprising the reaction mixture for producing the
product and (B) an aqueous phase adjacent to, but Substan
tially immiscible with the organic phase, the aqueous phase
containing at least one sensing agent that is different from the
first sensing agent and that
i also preferentially acts on the first stereoisomer in the
product, but with a different stereoselectivity for the
stereoisomers formed in the product than the first sens
ing agent to produce a monitorable change,
ii acts at equal rates on both formed Stereoisomers of the
product to produce a monitorable change or,
iii preferentially acts on a second stereoisomer in the
product to produce a monitorable change,
the product being diffusible into the aqueous layer (B),
conducting the reactions in the organic phases (1) and (A)
to produce the products,
allowing the products to diffuse into the aqueous phases (2)
and (B) and react with the first and second sensing agents,
monitoring the changes caused by the reactions with the
first and second sensing agents and
determining from the changes, the relative rate and stereo
selectivity of the organic chemical reaction in the organic
phases (1) and (2).
Another embodiment of the invention relates to a kit

adapted for efficiently carrying out the method of the inven
50

tion.
A further embodiment of the invention concerns a novel

method for identifying a catalyst for an organic chemical
reaction that efficiently forms a product that can exist as at
least two stereoisomers and that is also stereoselective for at
55

60
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least one of the Stereoisomers comprising:
providing a first reaction Zone containing (1) an organic
phase comprising the reaction mixture for producing the
product, the mixture containing a candidate catalyst for the
reaction and (2) an aqueous phase adjacent to, but Substan
tially immiscible with the organic phase, the aqueous phase
containing at least one first sensing agent that preferentially
acts on a first stereoisomer in the product to produce a moni
torable change, the product being diffusible into the aqueous
layer (2).
providing a second reaction Zone containing (A) an organic
phase also comprising the reaction mixture for producing the
product and (B) an aqueous phase adjacent to, but Substan
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FIG.3 shows Michaelis-Menten Kinetic Analysis: Km and

3
tially immiscible with the organic phase, the aqueous phase
containing at least one sensing agent that is different from the
first sensing agent and that

Vmax Determinations-HLADH.

FIG. 4 shows Michaelis-Menten Kinetic Analysis: Km and
Vmax Determinations-TBADH.

i also preferentially acts on the first stereoisomer in the
product, but with a different stereoselectivity for the
stereoisomers formed in the product than the first sens
ing agent to produce a monitorable change or
ii acts at equal rates on both formed Stereoisomers of the
product to produce a monitorable change or
iii preferentially acts on a second stereoisomer in the
product to produce a monitorable change,
conducting the reactions in the organic phases (1) and (A)
to produce the products,
allowing the products to diffuse into the aqueous phases (2)
and (B) and react with the first and second sensing agents,
monitoring the changes caused by the reactions with the
first and second sensing agents and
determining from the changes the relative rate of reaction
and stereoselectivity of the catalyst.

FIG. 5 shows a comparison of predicted and observed ee's
for the HKR oft-propylene oxide.
FIG. 6 shows a comparison of predicted and observed ee's
for the HKR of hexane oxide.
10
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FIGS. 7-7C show representative Co(III)-salen catalysts
utilized in the examples below (salens and the Co catalysts
prepared therefrom are numbered identically throughout the
specification)
FIG. 8 shows a plot of Dehydrogenase Enantiopreferences
vs. 1.2-Propanediol Concentration for HLADH.
FIG.9 shows a plot of Dehydrogenase Enantiopreferences
vs. 1.2-Propanediol Concentration for TBADH.
DETAILED DESCRIPTION OF THE INVENTION

The present invention is predicated on the discovery that

An additional embodiment of the invention relates to a

information on both the relative rates and stereoselectivities

method for preparing a catalyst for an organic chemical reac
tion that produces a product that can exist as at least two

for an array of reactions can be provided in situ by conducting
the reactions in parallel and observing the effects of the prod
ucts produced thereby whenacted upon by different reporting
agents, typically enzymes. The method of the invention dif
fers significantly from that disclosed in U.S. Pat. No. 6,974,
665. Specifically, (i) the reporting enzymes are used to
observe the reaction product directly (for example a chiral
1,2-diol), rather than a byproduct of catalyst turnover (for
example EtOH). This allows use of the chirality in the report
ing enzyme (chiral sensor). In addition (ii), two reporting
enzymes are employed, in parallel vessels, to obtain informa
tion on Stereoselectivity, as well as relative rates.
The invention permits, e.g., the screening of an array of
potential catalysts for reactions of interest, in parallel, and in
situ. For example, two enzymes with differing stereoselectiv
ity for the reaction product are employed. Each enzyme pro
vides, e.g., a spectroscopic signal (e.g. NADH or NADPH
formation) that can be detected by either UV/visible absorp
tion spectroscopy or fluorescence spectroscopy. This spectro
scopic signal can be followed in real time, while the reaction
is taking place.
The method of the invention utilizes techniques similar to

Stereoisomers and that is also stereoselective for at least one

of the stereoisomers comprising preparing a candidate cata
lyst for said reaction and:
providing a first reaction Zone containing (1) an organic
phase comprising the reaction mixture for producing said
product, said mixture containing a candidate catalyst for said
reaction and (2) an aqueous phase adjacent to, but Substan
tially immiscible with said organic phase, said aqueous phase
containing at least one first sensing agent that preferentially
acts on a first Stereoisomer in said product to produce a
monitorable change, said product being diffusible into said
aqueous layer (2).
providing a second reaction Zone containing (A) an organic
phase also comprising the reaction mixture for producing said
product and (B) an aqueous phase adjacent to, but Substan
tially immiscible with said organic phase, said aqueous phase
containing at least one sensing agent that is different from
said first sensing agent and that
i also preferentially acts on the first stereoisomer in the
product, but with a different stereoselectivity for the
stereoisomers formed in the product than the first sens
ing agent to produce a monitorable change or
ii acts at equal rates on both formed Stereoisomers of the
product to produce a monitorable change or
iii preferentially acts on a second stereoisomer in the
product to produce a monitorable change,
said product being diffusible into said aqueous layer (B),
conducting said reactions in said organic phases (1) and
(A) to produce said products,
allowing said products to diffuse into said aqueous phases
(2) and (B) and react with said first and second sensing agents,
monitoring the changes caused by said reactions with said
first and second sensing agents and
determining from said changes the relative rate and stereo
selectivity of said catalyst.

25

30

35

40

those disclosed in U.S. Pat. No. 6,974,665. The method of the
45

greater rate.
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BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a comparison of predicted and observed ee's
for the HKR oft-propylene oxide.
FIG. 2 shows a comparison of predicted and observed
relative rates (normalized to 4b) for Co(III)-salen mediated
HHR of propylene oxide.

invention is utilized to distinguish the situation in which
catalyst A has the same rate as catalyst B, but greater R:S
selectivity, from the situation in which catalysts A and B
display similar stereoselectivities, but catalyst A possesses a
The method does not require alteration of either the reac
tant or the product, by installation of a chromophore or mass
tag, for example. It has the further advantage of providing
information in real time, without the need to draw aliquots,
quench the reaction or perform a work-up.
The invention requires that the reaction to be screened
yield a product that reacts with the reporting (sensing) agent,
e.g., an enzyme. Potential “reporting enzymes' are screened
for both their substrate specificity and stereoselectivity. All
that is required is that one have two different reporting
enzymes that show different stereopreferences in their reac
tions with the Stereoisomeric organic reaction product of
interest. Reporting enzymes can be used for a variety of
reactions.

65

The method of the invention allows reliable predictions
that can lead to the discovery of a number of interesting
asymmetric catalysts. For example, the method has been used
to screen an array of new chiral Co(III)-salen catalysts for

US 7,767,388 B2
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their ability to catalyze the hydrolytic kinetic resolution
(HKR) of racemic, propylene oxide and hexene oxide.
The method may be utilized in the form of a screening kit.
The kit could contain, for example, separately packaged reac
tion vessels (e.g., cuvettes or microtitre plates), the organic
and aqueous liquid compositions, catalysts, buffers, and
enzymes. These compositions could be packaged with or
without organic and aqueous solvents. The kit could be pro
vided with or without catalysts. In other words, for a screen
ing kit without catalysts, the practitioner would supply his/her
own catalyst candidates or catalyst candidate library to be
screened. The kit could be provided with our without a test
substrate. In the latter case, the practitioner would provide

10

his/her own test substrate for the reaction of interest.

Typically, in accordance with the method of the invention,
two reaction vessels or two reaction wells containing an
organic layer and an aqueous layer are placed in parallel. Each
vessel contains the same organic layer and different aqueous
reporting layers.
To demonstrate proof of principle for the method of the
invention, the hydrolytic kinetic resolution (HKR) of (+)propylene oxide to 1,2-propane diol was chosen, a reaction
known to be catalyzed efficiently by chiral Co(III)-salencom
plexes. See Scheme 1. To provide an information-rich data set
requires that the two reporting enzymes display different,
ideally opposite stereoisomeric preferences. Preliminary
screening revealed that alcohol dehydrogenase from horse
liver (HLADH) and from Thermoaniaerobium brockii
(TBADH) fulfill this criterion. The former enzyme prefers
(S)-1,2-propanediol, whereas the latter favors the (R)-anti
pode. A focused 7x7"salen’ array was designed (Table S3) so
as to explore the interplay of novel chiral diamine scaffolds
(from terpenoid, amino acid, and carbohydrate skeletons)
with sterically and electronically diverse “salicylaldehydes,
from which the Co(III)-salen catalysts were prepared.

15

6
In the experiment, each Co(III)-salen catalyst (at 0.25
mol %) is placed in a lower organic layer (CHCl) and
expoxide, 300 uL total volume) in each of two parallel
cuvettes. Aqueous reporting layers containing TBADH/
NADP+ (cuvette 1) and HLADH/NAD+ (cuvette 2), respec
tively, are then added. The increase in absorbance at 340 nm
can be followed for several such sets in parallel by UV-vis
spectrophotometry. The kinetic data are then used to make the
double-cuvette ISES predictions. A comparison of the pre
dicted and measured ee's is presented in FIG. 1. Of 49 new
salens targeted, 42 were obtained, and 25 gave active Co(III)catalysts. Above a 65% ee threshold in either direction, ISES
found 9 of 11 true hits (18% false negatives) and succeeded in
9 of its 12 predictions (25% false positives). Note that the
measured ee's are for the HKR under the neat conditions

typically used in the conventional Jacobsen method whereas
the predicted ee's are for the bilayer used in double-cuvette
ISES. FIG. 2 compares the relative rates of reaction predicted

by ISES with those observed in a bilayer by "H NMR.

25

30

Observed relative rates agree with ISES predictions to within
25% in 9 of 10 cases measured, with the Co(III) salen catalyst
5d displaying slightly greater variance.
Interesting “combinatorial hits” include the finding that
2-hydroxy-1-naphthaldehyde (c) yields catalysts with very
low activity, whereas 1-hydroxy-2-naphthaldehyde (d) is the
best partner for beta-pinene-derived diamine 1. Furthermore,
a remarkable inversion of stereoselectivity is observed for
salens emanating from the new B-D-fructopyranose-based
diamine 7, upon going from the 3,5-di-tert-butylsalicylalde
hyde partner (a) to the sterically less encumbered 3,5-diiodo
congener (e).
The following will be understood by those skilled in theart.
Although the invention is illustrated with reference to the
hydrolysis of epoxides, the method of the invention is appli
cable for any organic chemical reaction that results in the

TBADH-cuvet

H3
aq. reporting layer 1
common organic layer

. reporting layer 2

US 7,767,388 B2
7
production of stereoisomers and particularly for Such reac
tions that employ catalysts. In those methods wherein an
alcohol is produced, the alcohol product may comprise a diol
Such as the 1,2-propane- and 1.2-hexane-diols exemplified
below or a halohydrin, a 3-azido alcohol, a 3-cyanoalcohol, a
B-alkoxy alcohol, a B-aryloxy alcohol, a B-thioalkyl alcohol,
B-amino alcohol, the product of an aldol-type condensation,
wherein a carbon acid having a proton alpha to one or more
electron-withdrawing groups (e.g., nitro group, carbonyl
group (aldehyde, ketone, ester, amide), cyano group, Sulfonyl
group, Sulfinyl group, Sulfoxide, phosphonate ester, isonitrile
group, imine functionality) is condensed with an aldehyde
and is deprotonated in the course of the condensation, the
product of a Morita-Baylis-Hillman reaction, the product of a
carbonyl reduction reaction or a cyanohydrin. The product
may also comprise an amine wherein the sensing agents are
amine dehydrogenase or amine oxidase enzymes that oxidize
the product. Where the product is an aldehyde or hemiacetal
the sensing agents in aqueous phases (2) and (B) may be
aldehyde or alcoholdehydrogenase enzymes that oxidize said
product.
Moreover, any Suitable reaction medium, i.e., solvent and
reaction adjuvants as well as aqueous medium may also be
employed in the practice of the invention. Although the inven
tion is illustrated employing enzymes as sensing agents, any
Suitable Such agent that preferentially reacts with a specific
Stereoisomer in the reaction product to produce a monitorable
change in the aqueous medium may be utilized. Suitable
enzymes include alcohol, amine or aldehyde oxidases or
dehydrogenases, it being understood that one may couple the
oxidase reaction with the (Horseradish) Peroxidase (HRP)
reaction, wherein the hydrogen peroxide byproduct from the
oxidase reaction leads to the oxidation of a dye co-substrate
for the peroxidase enzyme, producing an observable signal.
The monitorable change in the aqueous medium may also
comprise any effect that is measurable by Suitable and appro
priate monitoring techniques. In addition, the method of the
invention is applicable for the evaluation of suitable known
candidate catalysts as well as for the preparation of novel
catalysts for reactions that produce mixtures of stereoiso
mers. By the term, “relative rate' of organic chemical reaction

10
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is meant the relative rate of the reaction with reference to a

'standard’ reaction, i.e., another reaction under investigation
or a reaction known in the art.

All reactions were conducted under argon atmosphere
using flame or oven-dried glassware, unless otherwise indi
cated. Methylene chloride was distilled from CaFI. Toluene,
THF, and EtO were distilled from sodium benzophenone
ketyl. Methanol was distilled from Mg, and ethanol from
nadiethyl phthalate. Alcohol dehydrogenase from equine
liver (HLADH, EC 1.1.1.1), alcohol dehydrogenase from
Thermoanaerobium brockii (TBADH, EC 1.1.1.2), B-NAD+
(sodium salt), B-NADP+ (sodium salt), 3.5-Di-tert-butylsali
cylaldehyde (a), 3-tert-butylsalicylaldehyde (b), 2-hydroxy
1-naphthaldehyde (c), cobalt(II)-acetate tetrahydrate, 1-hy
droxy-2-naphthaldehyde (d), 3,5-diiodosalicylaldehyde (e),
4-benzyloxysalicylaldehyde (f) and 8-hydroxy-1,1,7,7-tet
ramethylulolidinyl-9-carboxaldehyde (g) were purchased.
Flash chromatography was performed using Merck silica
gel 60 (230-400 mesh). 1H NMR spectra were recorded on

45
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60

Bruker-DRX-Avance-400 MHz, 500 MHZ and 600 MHz

instruments with chemical shifts reported relative to residual
CHC (7.25ppm) and CHCl (5.2 ppm). Proton-decoupled

'C NMR spectra were acquired on Bruker-DRX-Avance

400 MHz, 500 MHZ and 600 MHZ instruments with chemical

shifts reported relative to CHCl (77.0 ppm). Optical rotation
(a)589 nm was measured at 19°C. in an Autopol polarimeter.

65
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IR spectra were obtained using a Nicolet Avatar 360 FTIR
spectrometer. Mass spectra were acquired at the Nebraska
Center for Mass Spectrometry (University of Nebraska-Lin
coln). Enzyme assays and ISES were done in a Shimadzu
UV-2101 PC spectrophotometer equipped with a CPS-260 six
cell positioner and thermoelectric temperature control (set at
25° C. for all experiments reported), or a Shimadzu 2401
spectrophotometer, equipped with a 12-cell changer and
water-jacketed cell holder for temperature control. Enantio
meric excesses were determined using a Chiralcel OD (0.46
mmx25 cm) chiral column.
General Procedure A: Synthesis of Chiral Salen Ligands
(illustrated for 2a). SeeTable S3 below.
An oven-dried RB flask was charged with (1S)-phenyl-1,
2-ethylenediamine (250 mg, 1.83 mmol) and 3,5-di-tert-bu
tylsalicylaldehyde (861 mg, 3.67 mmol) and freshly distilled
ethanol (2 mL). The reaction mixture was stirred at 45° C. for
1 d whereupon, in most cases, the salen product crystallized
out. The reaction temperature and time varied, as indicated in
the individual procedures. In the case of 2a, the product could
be obtained in pure form (823 mg, 79%) by simple trituration
with cold ethanol. If further purification was required, recrys
tallization or column chromatography was used.
N,N'-Bis(3',5'-di-tert-butylsalicylidene 1R-(1C.2C.
5O)-2-amino-7,7-dimethyl-2-bicyclo[3.3.1 heptane
ethanamine (1a)
Diamine 1 was prepared from commercially available
(1S)-(-)-3-pinene as described. General Procedure A was
followed. Diamine 1 (43.3 mg, 0.32 mmol) and 3,5-di-tert
butylsalicylaldehyde (150 mg, 0.64 mmol) were heated at
40-50° C. for 5 h, filtered and triturated (cold EtOH), to
produce clean la (140 mg, 92%): C.19 D+14.2 (c 3.54.
CHCl); 1H NMR (400 MHz, CDC1) & 1.23 (d. J=10 Hz,
1H), 1.23 (s.3H), 1.26 (s.9H), 1.26 (s.9H), 1.36 (s.3H), 1.43
(s, 9H), 1.43 (s.9H), 1.92-1.97 (m,3H), 2.03 (app t, J=11, 10
HZ, 1H), 2.17-2.26 (m, 2H), 2.28-2.32 (m, 1H), 2.42 (t, J–5.5
HZ, 1H), 3.70 (d. J=8 Hz, 1H), 3.91 (d. J=8 Hz, 1H), 6.98 (d.
J=2 Hz, 1H), 7.04 (d, J-2 Hz, 1H), 7.32 (d, J-2 Hz, 1H), 7.33
(d. J–2 Hz, 1H), 8.25 (s, 1H), 8.264 (s, 1H), 13.62 (brs, 1H),
14.36 (brs, 1H); 13C NMR (100 MHz, CDC1) & 23.9, 25.6,
25.8, 28.2, 28.6, 29.5, 31.47, 31.49, 34.1, 35.0, 35.1, 38.5,
40.0, 48.6, 67.2, 68.8, 117.8, 117.8, 126.0, 126.4, 126.6,
126.9, 136.5, 136.5, 139.6, 139.9, 158.1, 158.6, 162.69,

167.71; HRMS (FAB, 3-NOBA) calcd for CHNO.
(M+H)+ 601.4733, obsd. 601.47 10.
N,N'-Bis(3'-tert-butylsalicylidene)-1R-(1C.2O,5C.)2-amino-7,7-dimethyl-2-bicyclo[3.3.1 heptaneetha
namine (1b)
General Procedure A was followed. Diamine 1 (101 mg,
0.60 mmol) and 3-tertbutyl-2-hydroxybenzaldehyde (214
mg, 1.20 mmol), and chromatographic purification (5% EtN
hexenes), produced compound 1b (180 mg, 61%): C.19 D
+2.66 (c 4.65, CH,Cl); 1H NMR (400 MHz, CDC1) & 1.05
(d. J=10.8 Hz, 1H), 1.23 (s. 21H), 1.35 (s.3H) 1.89-2.06 (m,
3H), 2.13-2.31 (m,3H), 2.41 (appt, J–5.6, 5 Hz, 1H), 3.76 (d.
J=12 Hz, 1H), 3.86 (d. J=12 Hz, 1H), 6.84 (t, J=8 Hz, 2H),
7.10 (dd, J=9.0, 2 Hz, 2H), 7.29 (dt, J=9.2 Hz, 2H), 8.13 (s,
1H),8.17 (s, 1H), 13.12 (s, 1H), 13.63 (s, 1H); 13C NMR (100
MHz, CD.C.) & 23.8, 25.7, 28.2, 28.5, 31.39, 31.41, 33.9,
38.4, 40.0, 46.3, 48.3, 67.6, 68.9, 116.4, 166.5, 117.8, 117.9,
127.9, 129.4, 129.7, 140.9, 1412, 158.7, 159.2, 1618, 167.1;

HRMS (FAB, 3-NOBA) calcd for C.H.O.N. (M+H)+
489.3481, obsd 489.3492.
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B. Standardization of HLADH: The assay cuvette con
tained the following components: 7.2 mM (33 uL of 220 mM
stock) of NAD+, 2 uI of HLADH stock solution, 865uI of 50
mM sodium pyrophosphate buffer, pH 8.8, and 200 mM (100
uL of 2M stock) of (R)-1,2-propanediol. The reaction was
initiated by the addition of the (R)-1,2-propanediol, which
typically gave a rate of 0.25+0.01 Abs/min at 25°C., 340 nm.
This was indicative of 0.020 U of HLADH peruLofthe stock

26
TABLE S2-continued
Tabulated Dehydrogenase Enantioselectivities vs. Diol Concentration
1.2-Propanediol
Conc. (mM)
3

Solution.

VR vs of

C. Standardization of TBADH: The assay cuvette con
tained the following components: 2.2 mM (10 uI, 220 mM
stock) NADP+, 2I of TBADH stock solution, 888 uL of 50
mM sodium pyrophosphate buffer, pH 8.8, and 200 mM (100
uL of 2M stock) of (R)-1,2-propanediol. The reaction was
initiated by the addition of the (R)-1,2-propanediol, which
typically gave a rate of 0.275+0.001 Abs/min at 25°C., 340
nm. This was indicative of 0.022 U of TBADH per uL of the

15

25

Vsive of
HLADH

4

8

12

16

2O

30

40

50

1OO

4.O

3.6

2.8

2.4

2.7

2.8

3.0

2.7

2.6

30

40

50

60

8O

9.9

10.6

9.1

8.4

9.0

9.1

8.6

The flatness of each graph Suggests that Kim's for the two
enantiomers are likely not very different with either dehydro
genase. Indeed, this was confirmed by the determination of
Kim’s for each antipode of 1,2-propanediol for each enzyme.
For each antipodal diol, the same data as were used to Survey
dehydrogenase enantioselectivity, as a function of diol con
centration, were plotted in Michaelis-Menten fashion, as v0
vs. S (FIGS. 3 and 4). For each dehydrogenase, the data
curve for (R)-1,2-propanediol is shown by --, and those for
the (S)-enantiomer by -O-. In all four cases, the data were
processed by linear, least squares fitting to a hyperbolic func
tion. The resulting curve fits and best fit hyperbolic equations
are presented above. For HLADH, the following steady state
kinetic parameters were obtained:
Vmax=355+9 mAbs min-1 vs.

(S)-1,2-propanediol-Km=16+1 mM and
Vmax=819-20 mAbs min-1.
30

35

Translating these data into the ratio of catalytic efficiencies
for the two enantiomers, one obtains (Vmax/Km)S+(Vmax/
Km)R=3.6. This is consistent with the trends seen in enan
tioselectivity vs. concentration, as the HLADHenantioselec
tivity tends toward ~4:1 (S:R) as one tends toward low diol
concentrations (see Table S2 and FIGS. 8 and 9).
For TBADH, the following kinetic constants were
obtained:
(R)-1,2-propanediol-Km=17+2 mM and
Vmax=487-18 mAbs min-1 vs.

40

(S)-1,2-propanediol-Km=23+4 mM and Vmax=60+4
mAbs min-1.

45
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Here, the ratio of catalytic efficiencies for the two enantio
meric diols is dominated by the Vmax terms and yields
(Vmax/Km)R--(Vmax/Km)S=11. Again, one sees nice
agreement with trends observed in the enantioselectivity vs.
concentration data, where the enantioselectivity tends toward
~11:1 (R:S) as one tends toward low diol concentrations (see
Table S2 and FIGS. 8 and 9).
V. Double Cuvette-ISES (In Situ Enzymatic Screening) Pro
cedure

55

TABLE S2

Tabulated Dehydrogenase Enantioselectivities vs. Diol Concentration
1.2-Propanediol
Conc. (mM)

2O

(R)-1,2-propanediol-Km=25+2 mM and

The data are collected in FIGS. 8 and 9 and in Table S2

below. One sees that TBADH displayed a significant prefer
ence for the (R)-1,2-propanediol, and that HLADH favored
the (S)-antipode, though not to the same degree. For each
dehydrogenase, the relative velocities are relatively flat as a
function of diol concentration FIGS. 8 and 9. In each case,
there is a slight increase in enantioselectivity as one goes to
lower concentration, indicating that each enzyme displays the
same enantiomeric preference in the binding step (i.e. lower
Km) as in the catalytic step (higher kcat or Vmax).

10.8 8.9

10

10 TBADH

stock solution.

IV. Dehydrogenase Enantioselectivities
A. Relative Velocity (Vrel) Determinations
1. HLADH: The enantioselectivity of TBADH was esti
mated from the ratios of the initial velocities of (R)- vs.
(S)-1,2-propanediol at fixed concentrations between 4.0 and
100 mM at 25°C. Each velocity measurement was made in
duplicate. The assay cuvette contained the following: 7.2 mM
NAD+ (33 uL from a 220 mM stock), 0.049 U of HLADH,
and various concentrations of either the (R)- or (S)-enanti
omer of 1,2-propanediol. In all cases, the final Volume was
adjusted to 1 mL using 50 mM sodium pyrophosphate buffer,
pH 8.8. The concentration of NAD+ was fixed at saturating
levels here, as reported Kim values for NAD+ with HLADH
range from 38 to 629 uM.
2. TBADH: The enantioselectivity of TBADH was esti
mated from the ratios of the initial velocities of (R)- vs.
(S)-1,2-propanediol at fixed concentrations between 3.0 and
80 mM at 25°C. Each velocity measurement was performed
in triplicate. The assay cuvette contained the following: 2.2
mM NADP+ (10 uL from a 220 mM stock), 0.113 U of
TBADH, and various concentrations of either (R) or (S)enantiomer of 1,2-propanediol. In all cases, the final Volume
was adjusted to 1 mL using 50 mM sodium pyrophosphate
buffer, pH 8.8. The concentration of NADP+ was fixed at
saturating levels here, as reported Kim value for NADP+ with
TBADH is 13 uM.9

6

60

A general procedure for double cuvette-ISES to estimate
both enantioselectivities and relative rates for an array of
catalysts being screened in parallel is presented below. The
hydrolytic kinetic resolution (HKR) of (+) propylene oxide
was chosen as model reaction. An inverted bilayer with
CHC as the organic solvent was chosen for this study,
though initial trials indicate that other solvents both more
dense (alternative lower organic layers), and less dense (up
per organic layer) than the aqueous reporting layer, will also
work.
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Typically, quartz cuvettes with one cm light paths and with
nominal one mL. Volumes were used. For each catalyst, a two
cuvette Screen was performed, with cuvette A containing
HLADH, as (S)-propanediol-selective reporting enzyme, and
cuvette B containing TBADH, as a (R)-propanediol-selective
reporting enzyme. For each cuvette, the final volume was 800
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uL (300 uL of organic layer; 500 uL of aqueous layer). This
experimental set-up sent the spectrophotometer light beam
cleanly through the aqueous reporting layer, as control
experiments established that the beam passes through 1 mL
cuvettes between the 600 and 700 uL volume levels.
A. Organic Layer Composition:
Both cuvettes A and B had the following composition: 150
uL (2.15 mmol) of (+)-propylene oxide (7.2 M in organic
layer), 150 uL of CHCl and 0.25 mol%. Co(III)-salen cata- 10
lvst. The total organic laver volume was maintained as 300LL

y
9.
y
in all catalyst Screens.

l
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VI. Estimation of Enantioselectivity for Catalysts Screened
Previously, in monitoring transition metal-mediated allylic
substitution chemistry, ISES conditions were found in which
a reliable signal could be obtained in 10-20 min. For fast
catalysts, it was found that a 15 minute time window sufficed
to provide meaningful ISES rates in the two reporting
cuvettes, allowing for catalyst characterization. This time
window was employed for all catalysts displaying rates Sur
passing 50 mAbs/min (fastest rate of the two reporting
cuvettes). For catalysts exhibiting ISES rates s50 mAbs/min
over the first 15 minutes, a longer observation window WaS
chosen (35 minute total), so as to obtain a better signal.
Generally, catalysts displaying ISES rates of less than 20

B. Aqueous Layer Composition:
mAbs/min over 35 minutes were not pursued further.
The following expression was used to estimate catalyst
(i) Cuvette A: 0.35 UHLADH (17.6 uL from a stock is enantioselectivity:
solution (0.02 U/uL)), 7.2 mM B-NAD+(16.5 uL from a 220

mM stock) and 465.8 uL of 50 mM sodium pyrophosphate

(i. VE2 - ve

buffer, pH 8.8. The final pH was 8.6.

Catalyst Enantioselectivity= IRIA Selel

(ii) Cuvette B: 0.35 UTBADH (15.8 uL from a stock

S

Sele2 (VE - VE2)

solution (0.022 U/LL)) of 2.2 mM B-NADP+ (5 uL from a 20
220 mM stock) and 479.5 LL of 50 mM sodium pyrophoswhere the velocities in each of the reporting enzyme
phate buffer, pH 8.8. The final pH was 8.6. The total volume cuvettes, VE1 and VE2, respectively, were taken as the
of the aqueous layer was maintained as 500 uL in both AAbs/time values (typically the average of two runs) seen
cuvettes in all ISES experiments.

over the time window.

C. Step by Step Protocol: A catalyst stock solution (22 25 The parameters, Selei and Selle Were taken as the

umol of catalyst in 620 uL CHCl) was made up in a 1.5 ml
microcentrifuge tube, and stored on ice, along with a stock of

observed reporting enzyme enantioselectivies (a 40 mM diol
concentrations (see Table S2):

(t)-propylene oxide, in a separate tube. The organic layers

SelHLADH=E1=v RivS (HLADH)(a)40 mM=0.34

were prepared by briefly vortexing 150 uL (5.4 umol. 0.25
mol %) of the catalyst stock in CHCl with 150 uL (2.15 30
SelTBADH=E2=vRivS (TBADH)(a)40 mM=8.4.
mmol) of (t)-propylene oxide in iced microcentrifuge tubes.
This approximation was chosen, based upon the following
These were loaded into 1 mL quartz cuvettes using precooled considerations. Control experiments established that under
(refrigerator), disposable 1 mL Syringes. The aqueous layers ISES conditions, 1,2-propanediol concentrations in the aque
were then layered on top of the organic layers, by Syringe, ous layer were in the range of 2-100 mM, for active catalysts
down the walls of the cuvette. A reversed loading method was 35 over the observed time window.
adapted for the catalysts made using 1-hydroxy-2-naphthalThe enantiomeric excesses predicted from the double
dehyde (aldehyde 'd) in order to get a clear bilayer. In par- cuvette-ISES data, using this equation and empirical selec
ticular, it was found practical for these catalysts to load the tivity factors, for Co(III)-salen complexes in the library,
aqueous layer first. Then, the organic layer was syringed indexed by Salen, are displayed in the upper number in each
beneath the aqueous layer. Catalyst screens were routinely 40 box in Table S3 below. For comparison purposes, ee's deter
run in duplicate (i.e. two runs of cuvette A and two of cuvette mined for the same catalysts under standard Jacobsen con
B per screen), with ISES rates taken as the average of the two ditions (neat propylene oxide, no co-solvent, 0.55 equiv.
AO.D.340/time values obtained, for the appropriate time win- H2O, 3 h reaction time) are displayed below each prediction
dow (vide infra).

in the lower number.
TABLE S3

Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library
CHO

CHO

--

Bu

Bu

8.

C

b
d

NH
Me

NH2

2

--56

+68

--72

-75

S

-75
+81
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TABLE S3-continued
Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library
CHO

I

CHO

OH BO

CHO

OH
f

I

N

e

9.

Me

NH2

.

S

S

+4

S

-41"

Me

NH2
1

NH2

-41

-71

NH2

2

NH2

S

S

s

+43"

--57

S

+14

+51

NH2
3

NH2

NH2
4

NH2
O
Me

US 7,767,388 B2
TABLE S3-continued
Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library

- Me

+87 (+85)*

O
-O

S

+81 (+83)*

s

NH2

O
Me

x-d

NH2

Me
7
15

Each box provides data for the Co(III)-salen acetate

wherein:

derived from the indicated salen. Presented are the 96 ee of the

A and B are two chiral catalysts,
Sel, or Sel. V, (R:S) of the reporting enzyme for the

1.2-propanediol product, as predicted by double-cuvette
ISES (upper number), and as observed by chiral HPLC (lower
number). The cuvette experiments are run in a bilayer of pH
8.6 buffer over 7.2M epoxide in CHCl, containing 0.25 mol
% catalyst, for 15-35 min. Inherent catalyst ee's are judged
by running the HKR in neat propylene oxide, containing 0.55

equiv. of H2O, also at 0.25 mol % catalyst. These catalysts
gave ISES signals <20 mAbs min-1 over 35 min. This
catalyst was tested at 0.05 mol %, as it was especially fast.
"The catalysts derived from 2g and 4e displayed ISES rates of
14.9 and 18.1 mAbs min-1, respectively, in the HLADH
cuvette, over 35 min. Difficulty was encountered in synthe
sizing appreciable quantities of these salens. The 3,5-dini
trobenzoate counterion was employed for these Co (III) cata
lysts.
VII. Estimation of Relative Rates for Catalysts Screened
In order to rank catalysts in terms of relative rate, ISES

diol substrate, and

25

30

35

rates, VE1 and VE2, over the 15 minute time window, were

expression for enantioselectivity just discussed (Section VI).
For comparison purposes, these relative rate rankings were
compared with actual rate data obtained by observing diol
formation by 1H NMR (vide infra, Section IX). Since those
empirical data were normalized to the rate of the catalyst
derived from salen 3b, the predicted relative rates were simi
larly normalized. A comparison of the predicted and observed
rates is presented in FIG. 6.

v

A.

Sele2
(E)
(f, -vii.)
1+
Sele2

45

50

B

V2 - V1

Sele2-(v2 - v22)-

55

-- -

(E)-4-v2.
Sele2
Self

E2

El

(E ) (v2. - v£2)
Sele2
(i.
) v: - va,

60

Sele2-(vil- - via)
- -

-- -

(E) v.-vi.
Self

E2

double cuvette-ISES, were also evaluated outside of the

cuvette, under conditions more typically employed in HKR
reactions. Specifically, these Co(III)-salen catalysts were
evaluated in the HKR of (+)-propylene oxide, under neat
conditions, similar to those described by Jacobsen and
coworkers. Reactions were arbitrarily stopped after 3 hours,
to obtain the enantiopurity of the 1,2-propanediol product at
relatively early reaction times, for comparison with ISES
predictions.

40

éle

Sele1

A. Standard Jacobsen Conditions

Salens in the fully synthetic, 42 member focused library
that led to catalysts with appreciable activity, as indicated by

imported into the expression for total diolcatalyst A/total
diolcatalyst B shown below. Note that the selectivity factors

used here, SelE1 and SelB2, are the same as those used in the

V represents the observed rate with catalyst A or B and
enzyme E1 or E2.
VIII. Independent Measures of Enantioselectivity

El
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A typical procedure follows: To the Co(III)-salen catalyst
derived from 7e (5.4 mg, 5.4 umol, 0.25 mol %) and (+)propylene oxide (125 mg, 2.15 mmol) at 0°C., was added
water (21 ul, 1.18 mmol, 0.55 equiv.). The reaction mixture
was securely capped, and allowed to warm to room tempera
ture and stirred, most commonly for a total of 3 hours. Percent
conversion at 3 hours was evaluated by 1H NMR of an aliquot
(cooled to 0°C. for the transfer), in CDC1. In most of these
cases, the conversion was low enough after 3 hours, that the
unreacted epoxide (bp 32°C.) was of relatively low ee, and
was therefore removed by evaporation under aspirator
vacuum. When the conversion was less than 5% by NMR
after 3 hours, reactions were continued for longer times.
Upon termination of the reaction, the diol product was
isolated by Kugelrohr distillation (~120° C.-oven temp; 0.1
torr). To determine ee, the isolated diol was derivatized using
p-bromobenzoyl imidazole (2.2 equiv.) in THF in the pres
ence of NaH (4 equiv.) at room temperature for 5 min. The
bis(p-bromobenzoate) esters obtained following sequential
washes with 1 NHCl and saturated sodium bicarbonate, were

of sufficient purity to be used directly for chiral HPLC analy
sis (Chiralcel OD, 99% hexenefi-PrCH).
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-continued

7a.

M = Co(III), X = OAc

(+)

/ \

0.55 equiv. H2O

THF, rt
NaH (4 equiv.)

OH
Me

luo
R

O
N

/NN

\-l

Br

(2.5 equiv.)

Br

Br
O

Me

O

luo
R

O

Solvent: i-PrCH/hexane (1:99); Flow Rate = 1 mL/min
Retention Time: 14.1 (R) and 16.1 (S)
Integration: 376.6:135.6 (47% ee)
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-continued

M = Co(III), X = 3.5-Dinitrobenzoate

(+) A

0.55 equiv. H2O

OH

luoi

THF, rt

NaH (4 equiv.)
O

Me1 R

Br

(2.5 equiv.)

Br

Solvent: i-ProH/hexane (1:99); Flow Rate = 1 mL/min
Retention Time: 14.5 (R) and 16.6 (S)
Integration: 135.1:29.2 (64% ee)
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-continued

(+) H

M = Co(III), X = 3.5-Dinitrobenzoate
0.55 equiv. H2O

OH

THF, rt
NaH (4 equiv.)

1N1OH
Br

(2.5 equiv.)

Br

Br

Solvent: i-PrCH/hexane (1:99); Flow Rate = 1 mL/min
Retention Time: 14.5 (R) and 16.4 (S)
Integration: 10.1:135.3 (86% ee)
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TABLE S4-continued
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The concentration of 1,2-propanediol in the aqueous layer
was estimated under typical ISES conditions using 1H NMR

HKR Under Standard Jacobsen
with Co(III)-Salen
CatalystConditions
Hits

spectroscopy. The bilayer was prepared as usual for double

cuvette-ISES (Section V), but for the substitution of DO for

Loading

Salen (mol%) NMR conv. (time)
2g 0.25
n.d.

9% Yield (time)
1 (3h), 4 (20 h)

9% ee (HPLC)
-71 (a)3 h,

–65(a)20 h (R)

n.d. = not determined;

HO in the buffer, and the elimination of the dehydrogenase
enzymes. After 15 min, the aqueous layer (300 uL of 500 uL

10 total) was withdrawn and mixed with a fresh solution of

*Indicates that the Co(III)-3,5-dinitrobenzoate catalyst was used. All other entries are for

imidazole of known concentration (also 300 uL in D2O), as
an internal concentration standard. Accumulation of the 1H

Co(III)-salen-acetate catalysts,

B. Catalyst Performance in the ISES Cuvette
NMR spectrum, followed by integration and quantitation,
For several catalysts, control experiments were run to 15
assess whether running the HKR under biphasic conditions provided an experimental measure of total diol in the aque
influences the enantioselectivity of these Co(III)-salen HKR ous reporting layer at t=15 minutes for the catalyst under
catalysts. In Such cases, parallel duplicate double-cuvette
runs were chosen (i.e. two HLADH cuvettes and two TBADH investigation. The observed diol concentrations for ten cata

cuvettes for a single catalyst). Following the ISES runs, the 20 lysts examined in this way are collected in Table S6, below.

contents of all four reporting cuvettes were merged. Unre
acted epoxide was rapidly removed under Ar stream. Follow
ing dilution with CHCl (~50 mL), sodium sulfate was added

These have been normalized to the value for the catalyst
derived from salen3b (arbitrarily assigned a rate of 1.0).
TABLE S6

Co(III)-salen-Mediated HKR: I total 1.2-Propanediol by NMR (aqueous ISES layer
Salen
1a.

diol

19

2a

27.5

2b

22

1d

91

3b

96

4b

98

7e

37

Sa

Sb

52.5

75.5

Sd

54

(mM) (a) 15 min
Norm.

O.2O

O.29

O.23

O.9S

1.0

1.02

0.39

O.S.S.

O.79

O.S6

to adsorb remaining water. The resulting organic Solution was
The following examples illustrate the invention with
filtered and the filter cake washed with CHCl (2x20 mL). respect to an in situ enzymatic screening (ISES) method to
Following evaporation of the solvent, the crude diols were predict the enantioselectivity of chiral catalysts for the hydro
derivatized directly with p-bromobenzoyl imidazole to yield 40 lytic kinetic resolution (HKR) of (+) hexene oxide. Above, it
shown that the method of the invention may be employed
the 1,2-propanediol bis(pbromobenzoate) esters, which were was
to
predict
enantioselectivity and relative rate of a catalyst
then purified by silica gel chromatography to estimate diol library fortheHKR
of (+)-propylene oxide using horse liver
yields. Enantiomeric excesses were determined using chiral alcohol dehydrogenase (HLADH) and Thermoalaerobium

HPLC, as before. As can be seen from Table S5, there is no as broki alcohol dehydrogenase (TBADH). This example
appreciable erosion of ee seen in running these HKR experi-

demonstrates that an HKR substrate with a considerably

ments under biphasic conditions. Indeed, the ee's seen from

larger R grOup, hexene oxide, can also be screened by ISES

diol isolated directly out of the cuvette generally appear using a different enzyme couple. Specifically, Lactobacillus
slightly higher than those obtained under Jacobsen condi- Refir alcohol dehydrogenase (LKADH) shows a high (S)tions, probably reflecting the shorter reaction times 50 selectivity for the oxidation of 1.2-hexenediol and HLADH
shows a modest (S)-selectivity.
employed in the ISES experiment.
This example demonstrates greater breadth of the tech
TABLES5
nique, in terms of Substrate structure. Indeed, taken together,
the propylene oxide and hexene oxide cases, show that a
55 catalyst may be screened in a "cassette fashion” across more
Biphasic vs. Jacobsen Conditions
than one substrate, at once, in parallel, to give information
Co(III)-salen
% eeneasured 90 eeneasured 90 eeeredicted
(indexed by % Yield biphasic neat Jacobsen double cuvetSalen)
(isolated) conds.
conditions
ISES

about Substrate selectivity, as well as, enantioselectivity.
This example also shows that good ee predictions can be
made when using two reporting enzymes with the same enan

60 tiomeric preference, but with a significantly different magni
1a.

1

87

72

56

4a

1.6

82

76

77

4
e

tude of enantioselectivity.

In the experiment, each Co(III)-salen catalyst was mixed

with (t)-hexene oxide and dichloromethane and placed in a
lower organic layer in each of two parallel cuvettes. Aqueous

*denotes that the Co(III)-salen-3,5-dinitrobenzoate catalyst was used in this case. All other 65 reporting layers, containing LKADHANADP+ (cuvette 1)
entries refer to runs with Co(IID salen-acetate catalysts,
HLADHANAD+ (cuvette 2). were then added (Scheme 1).

The hexenediol product diffuses from the (lower) organic
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layer into the (upper) aqueous layer, where the HLADH and
LKADH enzymes act as sensors, oxidizing the product, and
producing the NAD(P)H signal. The increase of absorbance
at 340 nm is monitored in parallel by a UV-vis spectropho
tometer. Alternatively, the NAD(P)H fluorescence may be
monitored (emission wavelength is typically set at a fixed
value in the 460-470 nm), either in a cuvette or in a plate

5

48
chloride and 2M 2-propanol in H.O. Enzyme units were
calculated by measuring the rate of formation of NADH at
340 nm for both dehydrogenases (vide infra). In each case,
one S.I. unit is taken as the amount of enzyme catalyzing the
formation of one umol of NAD(P)H per minute.
Standardization of HLADH: The assay cuvette contained
the following components: 7.2 mM (33 uL) of B-NAD", 2 ul

format.

S-selective sensor

Aqueous layer
Organic layer

O

(+)

/ \
HO

Chiral Salen Catalyst

Cuvette II

NAD

S-selective sensor

Aqueous layer
Organic layer

O

(+)

/ \
HO

Chiral Salen Catalyst

60

Standardization of Reporting Enzymes
(or 20 uL of a 1:10 dilution) of HLADH stock solution, 865
The following stock Solutions were made for enzyme stanuL of 50 mM sodium pyrophosphate buffer, pH 8.8, and 200
dardization: 220 mM B-NAD", 220 mMBT-NADP", alcohol mM (100LL) of 2-propanol. The reaction was initiated by the
dehydrogenases from horse liver (HLADH) (0.01-0.02 U/uL) is addition of 2-propanol, which typically gave a rate of
and Lactobacillus kefir (LKADH) (0.05-0.07 U/uL) in 25
0.12+0.01 abs/min at 25°C., 340 nm. This was indicative of
mM sodium phosphate buffer, pH 7.0, 150 mM magnesium 0.010 U of HLADH per uL of the stock solution.
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Standardization of LKADH: The assay cuvette contained
the following components: 2.2 mM (10 uL) f-NADP, 1.5
mM (10 uL)MgCl2, 2 ul, (or 20 uL of 1:10 dilution) of
LKADH stock solution, 878 uL of 50 mM sodium pyrophos
phate buffer, pH 8.8, and 200 mM (100 uL) of 2-propanol.
The reaction was initiated by the addition of 2-propanol,
which typically gave a rate of 0.110+0.001 abs/min at 25°C.,
340 nm. This was indicative of 0.009 U of LKADH peruL of
the stock Solution.

5
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Double Cuvette ISES Procedure for HKR of Hexene Oxide

A general procedure for the double cuvette ISES to esti
mate the enantiomeric excess of the 1.2-hexenediol product
from the hydrolytic kinetic resolution (HKR) of racemic hex
ene oxide is described below. Quartz cuvettes with a 1 cm
light path and with a nominal 1 mL volume were used. For
every catalyst, a two cuvette Screen was performed, with
cuvette A containing HLADH, and cuvette B containing
LKADH. As indicated above, both enzymes are (S)-selective,
but differ in degree of selectivity.
Organic Layer: Both cuvettes A and B had the following
composition: 140 uL of (+)-hexene oxide (116 mg, 1.16
mmols) 160 uL of CHCl (Amylene stabilized, purchased)
and 2.0 mol % Co(III)-salen-acetate catalyst. The total
organic layer Volume was maintained as 300 uL in all catalyst

15

Soc. 2002, 124, 1307-1315). Reactions were stopped after 0.5
h, to obtain the enantiopurity of the 1.2-hexenediol produced
at relatively early reaction times, for comparison with bipha
sic ISES predictions.
A typical procedure follows: To the Co(III)-salen catalyst
derived from 1e (16.6 mg, 23.2 umol. 2.0 mol %) at rt was
added (+)-hexene oxide (116 mg, 1.16 mmols). The mixture
was cooled to 0°C. Then water (11.4 uL, 0.64 mmols, 0.55
equiv.) was added and the flask was capped tightly and stirred
25°C. for 30 min. The progress of the reaction was estimated

by H NMR, the reaction mixture was cooled to 0°C., an

25

SCCS.

Aqueous Layer in Cuvette A: 5.0LL (0.05 U with 2-pro
panol) of HLADH stock solution, (0.01 U/L), 16.5 uL (7.2
mM) of B-NAD" stock and 478.5 uL of 50 mM sodium
pyrophosphate buffer, pH 8.8.
Aqueous Layer in Cuvette B: 16.7 uL (0.15 U with 2-pro
panol) of LKADH stock (0.009 U/uL), 5 uL (2.2 mM) of
|-NADP" stock, 5 uL (1.5 mM) of MgCl, and 473.5 uL of 50
mM sodium pyrophosphate buffer, pH 8.8.
The total Volume of the aqueous layer was maintained as
500 uL in both cuvettes in all ISES experiments. For each
cuvette, 23 micromol of catalyst was dissolved in 160 uL of
water saturated CHCl in a 1.5 ml microcentrifuge tube. This
catalyst solution was kept at rt for 20-30 min. After that the
catalyst Solution was stored in an ice bath along with (E)hexene oxide separately. Every catalyst screen was done in
duplicate (i.e. two runs of cuvette A and two of cuvette B per
screen). Then the aqueous layers were prepared first in 1.5 mL
microcentrifuge tubes at 25°C. and drawn into 1 mL dispos
able syringes fitted with 19 gauge stainless steel needles. This
was done about 2 min before layering.
Following this, the organic layers were prepared in 1.5 mL.
microcentrifuge tubes by briefly mixing the catalyst Solution
with 140LL (1.16 mmols) of (+)-hexene oxide in an ice bath.
Immediately, they were loaded in 1 ml quartz cuvettes, using
1 mL disposable syringes. The aqueous layer was then added
carefully along the walls of the cuvette. A reversed loading
method (aqueous layer was loaded first inside the cuvette,
then the organic layer was loaded on the bottom by injecting
it slowly at the bottom of the cuvette through the aqueous
layer.) was adopted for the catalysts derived from 1-hy
drdoxy-2-naphthaldehyde to improve solubility. This was
followed by the parallel observation of continuous NAD(P)H
formation at 340 nm in both reporting cuvettes, using a
UV/vis spectrophotometer with six cell positioner at 25°C.
The enantiomeric ratio was predicted using the rate of
change of absorption (i.e. AAbs/time) from the 0-10 min
window for all catalysts. No prediction was attempted for
very slow catalysts (i.e., s 15 mAbs/min in 0-10 min time
window for HLADH cuvettes).

50
Hydrolytic Kinetic Resolution of (+)-Hexene Oxide
Co(III)-salen (acetate) catalysts were evaluated for HKR of
(t)-hexene oxide, under neat conditions, similar to those
described by Jacobsen and co-workers (Schaus, S. E.;
Brandes, B. D.; Larrow, J. F.; Tokunaga, M.: Hansen, K. B.:

30
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aliquot was then withdrawn and dissolved in CDC1 at 0°C.
bath. After distilling over the unreacted epoxide, the diol
product was collected, and then itself distilled again by
Kugelrohr. When the reaction conversion was more than 50%
in 30 min, 15 min reaction time was used (for catalyst 1e) to
get the product diol.
To determine ee, the isolated diol was derivatized using
p-bromobenzoyl imidazole (2.2 equiv.) in THF in the pres
ence of NaH (4 equiv.) at rt for 5 min. The bis(p-bromoben
Zoate) obtained following sequential washes with 1 NHCl
and bicarbonate (sat daqueous), was of Sufficient purity to be
used directly for chiral HPLC analysis Chiralcel OD, (99:1
hexanes/2-PrOH: 1 mL/min).
A number of “Co(III)-salen” catalysts (FIGS. 7-7C) were
subjected to "cassette screening” for the HKR of both (+)propylene oxide and (+)-hexene oxide, using UV/vis spec
troscopy. A comparison between the predicted and the mea
suredee's for the HKR of (+)-propylene oxide is presented in
FIG. 5. Above a 50% ee threshold, in either direction, ISES

found 5 of 5 hits (within a 21% ee margin). For the HKR of
(t)-hexene oxide, a comparison between the predicted and
the measuredee's is presented in FIG. 6. Above a 50% thresh
40

45
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old in either direction, ISES finds 7 of 7 hits within a 24% ee

margin. Note that this is particularly good since the biphasic
ISES conditions are being used to predict ee's measured
under Jacobsen's HKR conditions (“neat' epoxide, contain
ing 0.55 equivalents of water).
While the invention has been described with respect to
specific examples including presently preferred modes of
carrying out the invention, those skilled in the art will appre
ciate that there are numerous variations and permutations of
the above described systems and techniques that fall within
the spirit and scope of the invention as set forth in the
appended claims.
We claim:
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1. A method for monitoring the stereoselectivity of at least
one organic chemical reaction and the relative rate of at least
one organic chemical reaction, wherein the reaction produces
a product that can exist as at least two stereoisomers, the
process comprising:
providing a first reaction Zone containing (1) an organic
phase comprising the reaction mixture for producing
said product and (2) an aqueous phase adjacent to, but
Substantially immiscible with said organic phase, said
aqueous phase containing at least one first sensing agent
that preferentially acts on a first stereoisomer in said
product to produce a monitorable change, said product
being diffusible into said aqueous phase (2);
providing a second reaction Zone containing (A) an organic
phase also comprising the reaction mixture for produc

US 7,767,388 B2
51
ing said product and (B) an aqueous phase adjacent to,
but Substantially immiscible with said organic phase,
said aqueous phase containing at least one second sens
ing agent that is different from said first sensing agent

52
13. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are deter
mined by measurement of fluorescence in the UV or visible
region using a plate-reading fluorescence spectrophotometer.

and

i preferentially acts on the first stereoisomer in the
product, but with a different stereoselectivity for the
stereoisomers formed in the product than the first
sensing agent to produce a monitorable change or
ii acts at equal rates on both formed Stereoisomers of
the product to produce a monitorable change or
iii preferentially acts on a second stereoisomer in the
product to produce a monitorable change,
said product being diffusible into said aqueous phase
(B),
conducting said reactions in said organic phases (1) and
(A) to produce said product,
allowing said product to diffuse into said aqueous phases
(2) and (B) and react with said first and second sensing

14. The method of claim 1 wherein said reaction mixture

contains at least one catalyst for said reaction.
15. The method of claim 14 wherein said at least one
10

15

agents,

monitoring the changes caused by said reactions with said
first and second sensing agents and
correlating said changes to determine the relative rate and
stereoselectivity of said organic chemical reaction in
said organic phases (1) and (A).

25

2. The method of claim 1 wherein said first and second

sensing agents are enzymes.
3. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are spectro
Scopic.

30

4. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are visible to
the human eye, and are recorded photographically and quan
titated by analyzing image pixel density.
5. The method of claim 1 wherein said monitorable

35

changes produced in aqueous phases (2) and (B) are deter
mined by measurement of absorbance in the UV or visible
region of the spectrum.
6. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are deter
mined by measurement of fluorescence.

40

7. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are visible to
the human eye and are measured visibly or photographically
in a microtitre plate format.

45

8. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are visible to
the human eye and are measured visibly or photographically
in a reaction vessel or a multimicrocell.
9. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are mea
sured by UV/visible spectroscopy in cuvettes or a multimi
crocell, using a spectrophotometer equipped with an auto
mated cell positioner or with multimicrocell-reading
capability.

50
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10. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are mea
sured by UV/visible spectroscopy in a microtitre plate format.
11. The method of claim 1 wherein said monitorable

60

changes produced in aqueous phases (2) and (B) are deter
mined by measurement of fluorescence in the visible region
using the human eye or photography.
12. The method of claim 1 wherein said monitorable

changes produced in aqueous phases (2) and (B) are deter
mined by measurement of fluorescence in the UV or visible
region using a fluorescence spectrophotometer.

65

catalyst is a Co(III)-salen complex.
16. The method of claim 15 wherein said Co(III)-salen
complex is selected from the group consisting of

US 7,767,388 B2
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17. The method of claim 1 wherein said product is an
alcohol and said sensing agents in aqueous phases (2) and (B)

-continued
lo

O

O-Me

Yo

- 0

are alcohol dehydrogenase or oxidase enzymes that oxidize

Me

5
N

N

said product.

18. The method of claim 17 wherein said alcohol product is

a diol.

N^

19. The method of claim 18 wherein said diol is a 1,2-diol.

/No

20. The method of claim 19 wherein said diol is propane

C

10 1 2-diol or hexene-1,2-diol.

21. The method of claim 17 wherein the sensing agents are
Horse Liver Alcohol Dehydrogenase (HLADH) and Ther
Me

O-Me
lo

O

15

Yo

moanaerobium brocki Dehydrogenase (TBADH).
22. The method of claim 17 wherein the sensing agents are

Horse Liver Alcohol Dehydrogenase (HLADH) and Lacto

Me

bacillus kefir Dehydrogenase (LKADH).
SN

NS

23. The method of claim 17 wherein said alcohol is a

N/
I

O

20 halohydrin, a f-azido alcohol, a f-cyanalcohol, a f-alkoxy

/ AcO
N

alcohol, a 3-aryloxy alcohol, a B-thioalkyl alcohol, or a
B-amino alcohol.

I;

24. The method of claim 17 wherein said alcohol is the
I

Me

I

O-M

O

w

?o

25 product of an aldol-type condensation, wherein a carbon acid

e

having a proton alpha to one or more electron-withdrawing

NS

the course of the condensation.
25. The method of claim 17 wherein said alcohol is the

groups is condensed with an aldehyde and is deprotonated in
SN

N/

30 product of a Morita-Baylis-Hillman reaction.

/ N

26. The method of claim 17 wherein said alcohol is the

product of a carbonyl reduction reaction.
27. The method of claim 17 wherein said alcohol is a
BO

Me

OBn; and

O

35 cyanohydrin.

p -Me

28. The method of claim 1 wherein said product is an amine

Yo

and said sensing agents in aqueous phases (2) and (B) are
amine dehydrogenase or amine oxidase enzymes that oxidize
N

N

40 said product.

N/
/ N
O AcO

29. The method of claim 1 wherein said product is an
aldehyde or hemiacetal and said sensing agents in aqueous
phases (2) and (B) are aldehyde or alcohol dehydrogenase
enzymes that oxidize said product.
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